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Vibrio cholerae, the marine bacterium responsible for the diarrheal disease cholera, utilizes a 
multitude of virulence factors to cause disease. The importance of two of these factors, the 
toxin co-regulated pilus (TCP) and cholera toxin (CT), has been well documented for pandemic 
O1 and epidemic O139 serogroups. In contrast, endemic non-O1 and non-O139 serogroups 
can cause localized outbreaks of cholera-like illness, often in the absence of TCP and CT. One 
virulence mechanism used by these strains is the type VI secretion system (T6SS) to export 
toxins across the cell envelope and confer toxicity toward eukaryotic and prokaryotic organisms. 
The V. cholerae strain V52 (an O37 serogroup strain) possesses a constitutively active T6SS 
and was responsible for an outbreak of gastroenteritis in Sudan in 1968. To evaluate a potential 
role of the T6SS in the disease cholera, we compared the T6SS clusters of V. cholerae strains 
with sequenced genomes. We found that the majority of V. cholerae strains, including one 
pandemic strain, contain intact T6SS gene clusters; thus, we propose that the T6SS is a 
conserved mechanism that allows pandemic and endemic V. cholerae to persist both in the 
host and in the environment.
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TCP, we   studied the genetic basis for the virulent behavior of V. 
cholerae O37 serogroup strain V52, a highly virulent strain that 
caused 460 cases and 125 deaths during a local outbreak in Sudan 
in 1968 (Zinnaka and Carpenter, 1972). Using the social amoeba 
Dictyostelium discoideum as a host model, we found that the type 
VI secretion system (T6SS) functions as a potent virulence deter-
minant (Pukatzki et al., 2006).
It is not clear if expression of the T6SS is restricted to certain 
V. cholerae serogroups or whether it contributes to the human dis-
ease cholera. In this Perspective Article, we evaluate the possible role 
of the T6SS in the disease cholera by analyzing the presence of T6SS 
gene clusters in the genomes of various V. cholerae strains, including 
those responsible for the sixth (1899–1923) and the current seventh 
pandemic (>1961) (Sack et al., 2004).
The V. cholerae T6SS
Using the social amoeba D. discoideum as a host model, we identi-
fied a large conserved cluster of 17 genes (VCA0107–0123) plus 
two smaller auxiliary clusters (VCA0017–VCA0021 and VC1415–
VC1416) in the genome of V. cholerae strain V52 that encode a novel 
secretion system – the T6SS (Pukatzki et al., 2006).
Although  most  genes  in  the  V.  cholerae  type  VI  clusters 
(Figure 1A) are conserved hypothetical genes with unknown func-
tions, a few genes have putative functions as suggested by bioinfor-
matic analysis (Pukatzki et al., 2009), and a series of gene deletions 
linked these genes to virulence toward D. discoideum (Pukatzki 
et al., 2006, 2007). Based on bioinformatics and experimental data, 
T6SS genes fall into three functional classes: structural, regulatory, 
and effector.
InTroducTIon
Diarrheal diseases including cholera are a major cause of morbid-
ity and mortality in developing countries worldwide (Kosek et al. 
(2003); Bryce et al., 2005). Several million cases and over 120,000 
deaths result annually from cholera caused by the marine bacte-
rium Vibrio cholerae (World Health Organization, 1995). Upon 
ingestion of contaminated water, V. cholerae passes through the 
gastric acid barrier in the stomach and colonizes the small intestine 
(Zhu and Mekalanos, 2003) with the help of toxin-coregulated pili 
(TCP). The bacteria secrete cholera toxin (CT) that, when internal-
ized by epithelial cells of the small intestine, causes major water 
efflux into the gut lumen (Sack et al., 2004). As a result, V. cholerae 
leaves the human host during diarrheal purges (Larocque et al., 
2005).
Over 200 different V. cholerae serogroups have been classified 
so far, but only the O1 serogroup strains spread globally and cause 
pandemics. Bacteria from this serogroup (and others like O139) 
use TCP to autoaggregate in the small intestine and secrete CT 
(Sack et al., 2004). Besides CT and TCP, V. cholerae O1 serogroup 
strains require accessory toxins to cause cholera, as live vaccine 
strains with deleted CT and TCP genes still cause severe diarrhea 
(Fullner et al., 2002). These accessory toxins include virulence 
factors such as repeats-in-toxin (RTX) toxin, the zinc-dependent 
metalloprotease, hemagglutinin/protease (HA/protease), and HlyA 
hemolysin (Fullner et al., 2002). In contrast, most other serogroups 
(so-called non-O1, non-O139) are either avirulent or cause severe 
gastroenteritis (often in the absence of cholera toxin), but have 
not yet spread globally (Dziejman et al., 2002). In an attempt to 
identify virulence factors that function independently of CT and 
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in a similar fashion to puncture host membranes. We identified 
four T6SS components that show high structural homology with 
T4 bacteriophage proteins. These are the hemolysin-coregulated 
protein (Hcp) and three VgrG (valine-glycine-repeat protein G) 
proteins (VgrG1–3). Export of these four proteins requires the 
putative structural gene product VasK, which shows high similarity 
to the IcmF component of the type IV secretion system (T4SS) of 
Legionella pneumophila (Segal et al., 1998).
STrucTural componenTS
We do not know how the T6SS proteins assemble to form a secretion 
apparatus; however, several type VI proteins are structurally related 
to components of the T4 bacteriophage tail complex (Kanamaru 
et al., 2002). This protein complex is located at the distal tip of 
the syringe-shaped phage tail and allows the phage to puncture 
the bacterial envelope and inject its DNA into a bacterium. We 
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FIgure 1 | The V. cholerae Type VI Secretion System (T6SS). (A) The T6SS 
gene clusters. The three gene clusters contain genes of predicted (blue) and 
unknown (gray) functions. VCA0117 encodes the gene designated vasH. Also 
shown is the VasH-dependent regulation of the T6SS genes. (IHF , integration 
host factor). (B) Model for T6SS mechanics. Structural components form the 
base of the T6SS in the bacterial inner and outer membrane. A surface-exposed 
Hcp tube decorated with a VgrG trimer punctures a vesicular membrane to 
translocate effectors into the host cell (see text for details).www.frontiersin.org  November 2010  | Volume 1  | Article 117  |  3
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in V. cholerae (Figures 2B and C) and it will be exciting to determine 
if this heterogeneity contributes to the strain-specific regulation 
of T6SS genes.
effecTor componenTS
It  is  not  known  if  molecules  commonly  called “effectors”  are 
transported through the central channel of the type VI appara-
tus. Candidates for such soluble effectors are the autoinducer-2 
(AI-2)  binding  protein  RbsB  from  Rhizobium  leguminosarum 
(Bladergroen et al., 2003), EvpP from Edwardsiella tarda (Zheng 
and Leung, 2007), and AaiC from enteroaggregative E. coli (Dudley 
et al., 2006); however, V. cholerae does not carry homologs of these 
putative T6SS substrates.
dISTrIbuTIon of T6SS cluSTerS among V. cholerae 
STraInS
While the gene content differs tremendously between V. cholerae 
serogroups and strains in respect to virulence genes – including 
the genes encoding cholera toxin or the genes encoding the type 
III secretion system (T3SS) (Tam et al., 2007) – all V. cholerae sero-
groups sequenced thus far contain all three gene clusters involved 
in the T6SS (Figure 2A) (Pukatzki et al., 2006).
To assess the distribution of T6SS clusters in V. cholerae genomes, 
we compared V. cholerae strains for which sequenced genomes are 
available. As illustrated in Figure 2A, we included the O1 classi-
cal strain O395 (sixth pandemic), O1 El Tor strains M66-2 (pre-
seventh pandemic), and N16961 (seventh pandemic), the El Tor 
strain MJ-1236 that carries a classical biotype CTX prophage (so-
called hybrid strain), and the non-O1/non-O139 strains V52 (O37 
serogroup) and MZO-2 (O14 serogroup). Both V52 (Zinnaka and 
Carpenter, 1972) and MZO-2 (GenBank Taxonomy No. 417398) 
have been responsible for gastrointestinal illness that failed to 
become pandemic. The genome of V52 was used as the reference 
genome as this strain produces a functional T6SS (Pukatzki et al., 
2006). The large T6SS cluster of N16961 contains 285 single nucle-
otide substitutions of which 49 are non-synonymous substitutions 
that result in amino acid changes in all 17 genes of the V. cholerae 
type VI cluster.
We found a complete T6SS complement in each strain tested. 
The classical O1 strain O395 has four non-sense mutations, 
including a mutation in VCA0120 (vasK) that is essential for T6SS 
function (Pukatzki et al., 2006); thus the T6SS of the O1 strain 
O395 may be non-functional. Interestingly, one gene, VCA0122, 
encodes an 80-amino acid polypeptide in N16961, O395, M66-2, 
MJ-1236, and MZO-2, while the V52 genome encodes a shorter 
70-residue  protein  with  a  unique  27  residue  C-terminus.  It 
must be noted that truncation of the VCA0122-encoded pro-
tein in V52 does not correlate with impaired T6SS function, as 
V52 readily engages in T6SS-mediated toxicity (Pukatzki et al., 
2006). The unique VCA0122-encoded protein may contribute 
to the constitutive production of the V52 T6SS. The satellite 
cluster VCA0017-22 appears to be intact in all strains. While 
hcp-2 (VCA0017) and vgrG-2 (VCA0018) are highly polymorphic 
genes encoding full-length products, VCA0020 contains three 
extra codons in M66-2 and two extra codons in MZO-2 plus 
a one-codon deletion. The genes hcp-1 (VC1415) and vgrG-1 
(VC1416) are highly conserved and share identical sequences 
Bioinformatic analyses predict that the T6SS contains a tube-like 
structure. Monomers that could assemble into such a tube are the 
small 19-kD Hcp-proteins encoded by the two alleles VCA0017 
and VC1415, which share 98% similarity and encode identical pro-
teins. In support of this model, Ballister et al. (2008) found that 
recombinant Hcp from Pseudomonas aeruginosa readily assembles 
in vitro into hexameric rings to form nanotubes. Our bioinformatic 
analyses of VgrGs revealed that these T6SS components are mem-
bers of a novel protein family (Pukatzki et al., 2007). The recently 
solved crystal structure (Leiman et al., 2009) of a VgrG molecule 
from uropathogenic Escherichia coli confirmed our bioinformatic 
prediction that VgrG proteins form a trimeric cap similar to the 
cell-puncturing device of the T4 bacteriophage (Pukatzki et al., 
2007) (Figure 1B).
The current model (Figure 1B) proposes that after assembly 
of the VgrG-cap is completed, Hcp molecules form a hexam-
eric ring that may dock underneath the VgrG trimer to build a 
doublet ring with a continuous central pore. As more hexameric 
Hcp rings form and attach to the existing structure, the Hcp 
tube, decorated with a single trimeric VgrG-cap at its tip, may 
be pushed across the V. cholerae membrane into the extracel-
lular space. Interestingly, two VgrGs (VgrG-1 and VgrG-3) have 
evolved additional functions, such as actin-crosslinking, and serve 
as effectors when pushed into the host cytosol (Ma et al., 2009). 
Because the VgrG-cap lacks a channel, the tube is likely to be 
a gated complex (Leiman et al., 2009), in which case, the cap 
would need to dissociate from the complex for soluble substrates 
to pass through the Hcp channel. Recent findings by Ma et al. 
suggest that the actin-crosslinking domain of VgrG-1 is trans-
located in vivo, because infection of infant mice with V. cholerae 
strain V52 results in a T6SS-dependent inflammatory response 
and actin-crosslinking in cells of the small intestine (Ma and 
Mekalanos, 2010).
regulaTory componenTS
Our  transposon  mutagenesis  screen  identified  two  type  VI 
  regulators – VasH, positioned in the center of the large type VI 
cluster (Figure 1A), and rpoN, encoding the alternative sigma fac-
tor-54 (Pukatzki et al., 2006). Both vasH and rpoN mutants were 
attenuated in their ability to infect and kill D. discoideum. As vasH 
and rpoN mutant phenotypes are indistinguishable, they may act 
in the same regulatory pathway (Pukatzki et al., 2006).
VasH encodes a 59-kD protein that has the hallmarks of a sig-
ma-54-dependent regulator with domains that may function as 
(i) an N-terminal regulatory domain, (ii) an AAA +  central core 
with a putative ATP hydrolysis function, and (iii) a DNA binding 
domain with a conserved helix-turn-helix motif (Shingler, 1996; 
Schumacher et al., 2006) (Figure 2B). A vasH-null strain does not 
produce Hcp and is avirulent toward D. discoideum (Pukatzki et al., 
2006). Analyses of both hcp promoters revealed conserved binding 
sites for integration host factor and sigma-54 (Williams et al., 1996). 
Integration host factor bends DNA such that a sigma-54 activator 
bound to a distant upstream activation sequence can directly inter-
act with the promoter-bound sigma-54 of the RNA polymerase-
holoenzyme (Stonehouse et al., 2008). We predict that the same 
mechanism is true for VasH, which is highly expressed during 
human infections (Lombardo et al., 2007). VasH is   polymorphic Frontiers in Microbiology  |  Cellular and Infection Microbiology    November 2010  | Volume 1  | Article 117  |  4
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conserved. The fact that most mutations are silent and do not 
lead to truncated gene products suggests to us that V. cholerae 
is subjected to selective pressure that maintains an operative 
T6SS. It should be noted that even though V52 belongs to the 
non-O1/non-O139 group of V. cholerae, it is more closely related 
to the classical O1 strain O395 than to the El Tor strain N16961 
(Chun et al., 2009); yet, O395 accumulated at least four non-
sense mutations in the T6SS cluster while N16961 accumulated 
none. Thus, unlike N16961, O395 might have lost the need for 
a functional T6SS and has accumulated disabling mutations in 
the T6SS cluster.
in V52, N16961, M66-2, and MJ-1236. Hcp-1 of O395 shares an 
identical sequence with these strains, however its vgrG-1 con-
tains a 16-codon in-frame deletion and a non-sense mutation. 
Furthermore, VgrG-1 of MZO-2 is highly polymorphic and dif-
fers from V52 in 15 residues.
From a genomic perspective there is reason to believe that 
many V. cholerae strains, including post-sixth pandemic strains, 
carry functional T6SSs. Even though important T6SS genes are 
polymorphic, the vast majority of nucleotide substitutions are 
synonymous and do not alter the sequence of the encoded pro-
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FIgure 2 | T6SS clusters in V. cholerae strains with sequenced genomes. 
(A) Genomic alignments. Nucleotide sequences used for this study were 
obtained from Broad Institute and NCBI databases and compared with the 
blastn program from the stand-alone NCBI BLAST application (version 2.2.21). 
In-house Perl scripts were written to parse BLAST output and to compare 
genomic sequences of gene models for variations. BioPerl (http://www.bioperl.
org/) modules were used. Regions containing the T6SS clusters of various 
V. cholerae strains (names on the left) were aligned. Each gene is indicated by a 
box in a color distinct for a particular strain. A vertical bar and an asterisk indicate 
the 3′-end of a truncated gene. Codon insertions are indicated by red triangles, 
while deletions are indicated by yellow triangles with numbers that indicate the 
insertion/deletion size (number of codons). Rough ends of a gene indicate that 
the complete sequence was not available. (B) Polymorphic domains of VasH. 
Graphical depiction of VasH from the O37 serogroup strain V52 (V52_VasH) with 
its putative N-terminal regulatory domain (blue), core sigma-54 activator domain 
(pink), and C-terminal helix-turn-helix (HTH) domain (yellow) (drawn to scale). 
Conserved amino acid substitutions are indicated by arrows. The residue and its 
position in VasH of V52 is indicated below the line and the substitutions found in 
other strains are indicated above the arrowhead. (C) Allelelic VasH variants. 
Listed are VasH variants of different V. cholerae strains compared to VasH in V52.  
Amino acid substitutions are listed for each variant. Font color indicates in which 
of the three domains the substitution is located.www.frontiersin.org  November 2010  | Volume 1  | Article 117  |  5
Miyata et al.  Type VI secretion and cholera
  eukaryotic phagocytes (Pukatzki et al., 2006). The structural homol-
ogy of the T6SS and the cell-puncturing device of the T4 bacteri-
ophage suggests that the T6SS can target bacteria, an activity that has 
been demonstrated experimentally for V. cholerae (MacIntyre et al., 
2010), P. aeruginosa and Burkholderia thailandensis (Hood et al., 2010; 
Schwarz et al., 2010).
We propose that V. cholerae uses its T6SS to outcompete bacterial 
neighbors as well as eukaryotic predators like mammalian immune 
cells and amoebae. As shown in Figure 3, V. cholerae must colonize the 
small intestine to initiate an infection. However, the epithelial lining 
of the small intestine contains commensal bacteria, some of which 
secrete products harmful to V. cholerae (step 1). V. cholerae passes the 
gastric acid barrier can reach the lumen of the small intestine (step 
2) where it may turn on its T6SS to kill commensal bacteria to clear 
competitors from epithelial surfaces required for colonization (step 3). 
Activation of the T6SS likely involves the putative transcriptional acti-
vator VasH, which we hypothesize activates RNA polymerase bound to 
the sigma-54 binding sites of selective promoters. We do not know how 
VasH is regulated, but bioinformatics analysis allows us to speculate 
that VasH may function as the receiver module of a yet to be identi-
fied two-component system that is activated in response to unknown 
external stimuli. Once activated, VasH triggers the expression of genes 
encoding important structural proteins such as Hcp and VgrG. As V. 
cholerae multiplies and continues to kill adjacent commensals, it begins 
to secrete cholera toxin (step 4). The infection is recognized by the host, 
and phagocytic immune cells invade the area to clear the infection. As 
V. cholerae is phagocytosed, the T6SS is activated to kill the infected 
immune cells (step 5), thereby allowing the infection to proceed. If 
this model is correct, it would be interesting to determine if there are 
distinct environmental signals that activate the T6SS depending on 
whether they are challenged by immune cells or other prokaryotic 
competitors. The release of cholera toxin triggers massive water efflux 
into the gut lumen, and V. cholerae leaves the small intestine during 
diarrheal purges (step 6). V. cholerae leaving the human host is primed 
to ward off bacterial and amoeboid predators in the environment they 
are about to encounter (step 7).
expreSSIon of The T6SS complemenT
If some endemic and pandemic V. cholerae strains carry a functional 
T6SS complement, we need to understand why some strains use 
their system constitutively under laboratory conditions while oth-
ers do not (Pukatzki et al., 2006). One explanation is that strains 
regulate their systems differently: while some clinical and environ-
mental V. cholerae strains express the T6SS constitutively, pandemic 
strains may be more selective. There is precedence for strain-specific 
regulation of virulence genes in V. cholerae: the ToxR regulons of 
classical and El Tor strains require different in vitro growth condi-
tions to express the genes encoding CT and TCP, while the classical 
O1 strain 569B expresses CT and TCP constitutively (Majumder 
et al., 1996). We hypothesize that the T6SS behaves similarly such 
that pandemic strains require yet to be identified signals, while V52 
expresses its T6SS in the absence of such signals.
The fact that the T6SS genes identified in V52 are maintained in 
the pandemic El Tor strain N16961 implies that the T6SS genes are 
under selection in N16961 and have not drifted. One reason that 
N16961 does not kill amoebae may be that this strain uses a regula-
tory T6SS network that is not activated under laboratory conditions. 
Genomic comparison of vasH (VCA0117), the gene that encodes the 
T6SS regulator VasH, revealed that VasH is polymorphic and differs 
between strains (Figures 2B and C). The polymorphisms occur in 
interesting places: 10 conserved amino acid substitutions give rise 
to 10 variants. Five substitutions occur in the putative regulatory 
N-terminal domain, and the only substitution in the activator core 
domain is located just 27 residues downstream from the Walker B 
motif. Three substitutions are located between the core domain 
and the DNA-binding domain. It will be interesting to see if the 
polymorphic nature of the T6SS cluster, including vasH, accounts 
for the different utilization of this virulence determinant.
a WorkIng model
If the T6SS is a universal feature used by V. cholerae, then how does 
the T6SS contribute to the persistent and virulent behavior of V. chol-








FIgure 3 | A model for the role of the T6SS in persistence and virulence of 
V. cholerae. (1) The small intestine colonized with commensal bacteria is 
(2) invaded by V. cholerae cells that passed the gastric acid barrier. (3) Upon 
descent into the ducts between adjacent villi of the small intestine, V. cholerae 
assembles the T6SS on its surface (indicated by black spikes) in order to kill 
commensal microorganisms. (4) The sterile patches generated allow V. cholerae 
to colonize and multiply. (5) Incoming immune cells that ingest V. cholerae are 
killed by the T6SS-mediated toxicity, allowing the infection to proceed. (6) 
Secretion of cholera toxin results in massive water efflux into the host lumen, 
and V. cholerae cells leave the human host during diarrheal purges. (7) 
V. cholerae exiting the body maintain T6SS activation in preparation for bacterial 
and eukaryotic predators in the environment.Frontiers in Microbiology  |  Cellular and Infection Microbiology    November 2010  | Volume 1  | Article 117  |  6
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